NEW YORK (GenomeWeb News) – Abbott today reported 3 percent first quarter growth for its diagnostics business including a 5 percent increase in year-over-year molecular diagnostics sales.

The firm reported overall diagnostics dales of $1.12 billion for the three months ended March 31, up from $1.09 billion for Q1 2013. On an operational basis, its diagnostics sales were up 5 percent. It said that the diagnostics business was hit by a 2.5 percent negative effect from foreign exchange.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.